THH - Supply of Patient-Specific Cytotoxic and Advjuvant Products
Estimated value
—
Awarded value
£9.3m
Awarded 27 May 2026
Suppliers
1
Lots
1
1 awarded
Published
10 Jun 2026
Description
Provision of Patient specific Cytotoxic and Adjuvant products as and when required.
Scope
- Reference
- C392954
- Commercial tool
- Standalone contract
- Contract dates
- 03 Feb 2026 to 02 Feb 2029Possible extension to 02 Feb 2031
Option to extend by 24 months based on trust requirements
- CPV classifications
- 33000000
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Commercial | Commercial | cost | 30.00% |
| technical | Technical | quality | 60.00% |
| Social Value Envelope | Social Value | quality | 10.00% |
Participation
Conditions suppliers must meet to bid.
Included within ITT packs
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£9.3m
Award date
27 May 2026
Contract start
30 Jun 2026
Contract end
30 Jun 2029
Awarded to
BA
CH 00461365